Filters Vaccine RSV (Respiratory Syncytial Virus) VaccineThis study will measure the immune response to the vaccine. View Trial DetailsAges: 18 - 49Reimbursement: up to $300Trial Length: Up to 28 days Vaccine RSV (Respiratory Syncytial Virus) VaccineThis study is testing a new vaccine to protect women from getting sick from RSV. View Trial DetailsAges: 18 - 49Reimbursement: up to $300Trial Length: Up to 6 months Vaccine RSV (Respiratory Syncytial Virus) VaccineThis study will explore whether giving the study vaccine may help protect against RSV infection in people ages 60 and older. View Trial DetailsAges: 60 +Reimbursement: up to $500Trial Length: Up to 3 years
